BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35888599)

  • 1. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
    Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.
    Bhatia V; Goel MM; Makker A; Tewari S; Yadu A; Shilpi P; Kumar S; Agarwal SP; Goel SK
    Biomed Res Int; 2014; 2014():248419. PubMed ID: 24991542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.
    Alvarez MC; Santos JC; Maniezzo N; Ladeira MS; da Silva AL; Scaletsky IC; Pedrazzoli J; Ribeiro ML
    World J Gastroenterol; 2013 May; 19(20):3043-51. PubMed ID: 23716983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant gene promoter methylation of E-cadherin, p16
    Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
    Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.
    Ferlazzo N; Currò M; Zinellu A; Caccamo D; Isola G; Ventura V; Carru C; Matarese G; Ientile R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
    Wang W; Li X; Wang F; Sun XY
    J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.
    Mikeska T; Bock C; El-Maarri O; Hübner A; Ehrentraut D; Schramm J; Felsberg J; Kahl P; Büttner R; Pietsch T; Waha A
    J Mol Diagn; 2007 Jul; 9(3):368-81. PubMed ID: 17591937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
    Santos JC; Bastos AU; Cerutti JM; Ribeiro ML
    BMC Cancer; 2013 Feb; 13():79. PubMed ID: 23414134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.
    Tournier B; Chapusot C; Courcet E; Martin L; Lepage C; Faivre J; Piard F
    BMC Cancer; 2012 Jan; 12():12. PubMed ID: 22243995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes
    Sanchez H; Hossain MB; Lera L; Hirsch S; Albala C; Uauy R; Broberg K; Ronco AM
    Clin Epigenetics; 2017; 9():74. PubMed ID: 28748002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis.
    Dvojakovska S; Popovic-Monevska D; Grcev A; Pancevski G; Benedetti A; Popovski V; Dimovski A; Stamatoski A
    J Craniomaxillofac Surg; 2018 Oct; 46(10):1737-1740. PubMed ID: 30100382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
    Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
    Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues.
    Kupčinskaitė-Noreikienė R; Skiecevičienė J; Jonaitis L; Ugenskienė R; Kupčinskas J; Markelis R; Baltrėnas V; Sakavičius L; Semakina I; Grižas S; Juozaitytė E
    Medicina (Kaunas); 2013; 49(8):361-6. PubMed ID: 24509146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.